Who Owns Tarsus Pharmaceuticals Stock?
NASDAQ: TARSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 99.75%
- Institutions (% of float)
- 102.51%
- Held by insiders
- 2.69%
- Institutional holders
- 358
- Institutions 97.3%
- Insiders 2.7%
- Public and other 0.0%
Who owns Tarsus Pharmaceuticals stock?
Institutional investors own about 99.8% of Tarsus Pharmaceuticals's shares, spread across 358 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.69% of TARS.
The largest institutional holders are Blackrock Inc. (8.79%), Deep Track Capital, Lp (8.36%) and RTW Investments LP (7.65%). Together, the top 10 institutions control 56.4% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their TARS positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TARS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 3.86M | 8.79% | +8.5% |
| Deep Track Capital, Lp | 3.67M | 8.36% | +1.9% |
| RTW Investments LP | 3.36M | 7.65% | +0.3% |
| Jupiter Topco LLC | 2.81M | 6.40% | +100.0% |
| Paradigm Biocapital Advisors LP | 2.78M | 6.33% | +8.3% |
| Morgan Stanley | 1.83M | 4.16% | -6.0% |
| Vanguard Capital Management LLC | 1.79M | 4.09% | +1.9% |
| Jennison Associates LLC | 1.66M | 3.79% | -2.8% |
| Tang Capital Management, LLC | 1.57M | 3.57% | +31.9% |
| Millennium Management Llc | 1.43M | 3.25% | +152.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TARS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.30M | 2.95% |
| iShares Trust-iShares Russell 2000 ETF | 1.07M | 2.45% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 457.87K | 1.04% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 455.51K | 1.04% |
| Prudential Jennison Small Co Fd., Inc.-PGIM JENNISON SMALL COMPANY Fd. | 408.23K | 0.93% |
| iShares Trust-iShares Russell 2000 Growth ETF | 392.17K | 0.89% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 360.00K | 0.82% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 346.74K | 0.79% |
| IVY FUNDS-Nomura Small Cap Growth Fund | 342.28K | 0.78% |
| Legg Mason Partners Investment Trust-ClearBridge Small Cap Growth Fund | 309.49K | 0.71% |
Frequently asked questions
Who is the largest shareholder of Tarsus Pharmaceuticals?
Blackrock Inc. is the largest institutional shareholder of TARS, owning 8.79% of shares outstanding (3.86M shares) as of its latest 13F filing.
What percentage of Tarsus Pharmaceuticals is owned by institutions?
Institutions own about 99.8% of TARS shares and 102.5% of the public float.
How much of Tarsus Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 2.69% of TARS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.